The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21
Deok Soo Son, Andrew J. Wilson, Angelika K. Parl, Dineo Khabele
Dive into the research topics of 'The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21'. Together they form a unique fingerprint.